prednisone has been researched along with Appetite Disorders in 5 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a Nordic multi-centre trial, 583 previously untreated multiple myeloma patients were randomized to receive melphalan-prednisone or melphalan-prednisone+ interferon alpha-2b at a dose of 5 million units subcutaneously, 3 d/week." | 9.08 | Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group. ( Hjorth, M; Kaasa, S; Westin, J; Wisløff, F, 1996) |
| "In a Nordic multi-centre trial, 583 previously untreated multiple myeloma patients were randomized to receive melphalan-prednisone or melphalan-prednisone+ interferon alpha-2b at a dose of 5 million units subcutaneously, 3 d/week." | 5.08 | Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group. ( Hjorth, M; Kaasa, S; Westin, J; Wisløff, F, 1996) |
| "Treatment with prednisone is preferable, followed by immunosuppressive therapy or tamoxifen in case of resistance to steroids." | 1.34 | [Fatigue, loss of appetite and anuria due to retroperitoneal fibrosis]. ( de Beus, E; Rensma, PL, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| RAZON, S | 1 |
| MAZZOLA, G | 1 |
| de Beus, E | 1 |
| Rensma, PL | 1 |
| Wisløff, F | 1 |
| Hjorth, M | 1 |
| Kaasa, S | 1 |
| Westin, J | 1 |
| Mertz, DP | 1 |
| Stutz, FH | 1 |
| Blom, J | 1 |
| Tormey, DC | 1 |
1 trial available for prednisone and Appetite Disorders
| Article | Year |
|---|---|
Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group.
Topics: Activities of Daily Living; Aged; Antineoplastic Combined Chemotherapy Protocols; Fatigue; Feeding a | 1996 |
4 other studies available for prednisone and Appetite Disorders
| Article | Year |
|---|---|
[IMMEDIATE EFFECTS OF CORTICOSTEROID THERAPY IN GRAVE JAUNDICE OF THE NEWBORN].
Topics: ABO Blood-Group System; Adrenal Cortex Hormones; Betamethasone; Birth Weight; Dyspepsia; Erythroblas | 1964 |
[Fatigue, loss of appetite and anuria due to retroperitoneal fibrosis].
Topics: Aged; Anemia; Anti-Inflammatory Agents; Anuria; Diagnosis, Differential; Fatigue; Feeding and Eating | 2007 |
[Therapy of thinness].
Topics: Body Weight; Cyproheptadine; Emaciation; Feeding and Eating Disorders; Fructose; Glucose; Growth; Hu | 1972 |
Combination chemotherapy in disseminated carcinoma of the breast.
Topics: Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Evaluation Stu | 1974 |